|
|
 Previous Article | Table of Contents | Next Article 
A Three Amino Acid Deletion in Glycoprotein IIIa Is Responsible for Type I Glanzmann's Thrombasthenia: Importance of Residues Ile325Pro326Gly327 for  3 Integrin Subunit Association
Marie-Christine Morel-Kopp,
Cécile Kaplan,
Valérie Proulle,
Vincent Jallu,
Chantal Melchior,
Olivier Peyruchaud,
Marie-Hélène Aurousseau, and
Nelly Kieffer
From the Service d'Immunologie Leucoplaquettaire, GIP-INTS, Paris, France; UMR 5533 CNRS, Hôpital Cardiologique, Pessac, France; the Laboratoire d'Hématologie, Hôpital Jean Verdier, Bondy, France; and the Laboratoire Franco-Luxembourgeois de Recherche Biomédicale, Centre Universitaire, Luxembourg.
Glanzmann's thrombasthenia (GT) is a recessive autosomal bleeding disorder characterized by abnormal platelet aggregation due to a qualitative or quantitative defect of the glycoprotein (GP) IIb-IIIa complex (integrin  IIb 3). We describe a new mutation in the GPIIIa gene responsible for type I GT in a consanguineous Algerian family. A discordance between phenotyping and genotyping of the GPIIIa-related HPA-1 platelet alloantigen system in three family members heterozygous for the disease suggested a genetic defect in the GPIIIa gene and a normal GPIIb gene. Sequence analysis of amplified genomic DNA fragments showed a 6-bp deletion in exon 7 of the GPIIIa gene resulting in the amino acid deletion/substitution (Ile325Pro326Gly327  Met) and creating a new BspHI restriction site. Expression of the mutated integrin 3 subunit cDNA in Chinese hamster ovary cells showed that the cDNA gene was transcribed into a full-length 3 protein with an apparent molecular weight identical to wild-type 3 and accumulated as a single-chain molecule in the cell cytoplasm. The absence of heterodimeric complex formation of the mutant 3 protein with endogeneous v was shown by immunoprecipitation experiments, intracellular immunofluorescent labeling, and a semiquantitative enzyme-linked immunosorbent assay using the v3 complex-specific monoclonal antibodies LM609 and 23C6. Substitution of the methionine residue by a proline, present at position 326 of wild-type 3, did not restore the ability of the recombinant mutant 3 protein to associate with v, suggesting that the Ile-Pro-Gly motif is located in a 3 domain important for integrin subunit interaction. The association of a BspHI restriction site with this newly identified mutation has allowed allele-specific restriction analysis of Algerian GT individuals and the identification of two new unrelated type I patients exhibiting the same mutation, suggesting that the described mutation might be significant in this population and that BspHI restriction analysis will provide a useful screening assay for antenatal diagnosis and genetic counselling.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 669-677
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Rosenberg, R. Yatuv, V. Sobolev, H. Peretz, A. Zivelin, and U. Seligsohn
Major mutations in calf-1 and calf-2 domains of glycoprotein IIb in patients with Glanzmann thrombasthenia enable GPIIb/IIIa complex formation, but impair its transport from the endoplasmic reticulum to the Golgi apparatus
Blood,
June 15, 2003;
101(12):
4808 - 4815.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hermand, P. Gane, M. Huet, V. Jallu, C. Kaplan, H. H. Sonneborn, J.-P. Cartron, and P. Bailly
Red Cell ICAM-4 Is a Novel Ligand for Platelet-activated alpha IIbbeta 3 Integrin
J. Biol. Chem.,
February 7, 2003;
278(7):
4892 - 4898.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Yatuv, N. Rosenberg, A. Zivelin, H. Peretz, R. Dardik, L. Trakhtenbrot, and U. Seligsohn
Identification of a region in glycoprotein IIIa involved in subunit association with glycoprotein IIb: further lessons from Iraqi-Jewish Glanzmann thrombasthenia
Blood,
August 15, 2001;
98(4):
1063 - 1069.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. K. Boudreaux and D. L. Lipscomb
Clinical, Biochemical, and Molecular Aspects of Glanzmann's Thrombasthenia in Humans and Dogs
Vet. Pathol.,
May 1, 2001;
38(3):
249 - 260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D Inwald, E G Davies, and N Klein
Demystified ...: Adhesion molecule deficiencies
Mol. Pathol.,
February 1, 2001;
54(1):
1 - 7.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. L. Lipscomb, C. Bourne, and M. K. Boudreaux
Two Genetic Defects in {alpha}IIb Are Associated with Type I Glanzmann's Thrombasthenia in a Great Pyrenees Dog: A 14-base Insertion in Exon 13 and a Splicing Defect of Intron 13
Vet. Pathol.,
November 1, 2000;
37(6):
581 - 588.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Gonzalez-Manchon, M. Fernandez-Pinel, E. G. Arias-Salgado, M. Ferrer, M.-V. Alvarez, S. Garcia-Munoz, M. S. Ayuso, and R. Parrilla
Molecular Genetic Analysis of a Compound Heterozygote for the Glycoprotein (GP) IIb Gene Associated With Glanzmann's Thrombasthenia: Disruption of the 674-687 Disulfide Bridge in GPIIb Prevents Surface Exposure of GPIIb-IIIa Complexes
Blood,
February 1, 1999;
93(3):
866 - 875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Peyruchaud, A.T. Nurden, S. Milet, L. Macchi, A. Pannochia, P.F. Bray, N. Kieffer, and F. Bourre
R to Q Amino Acid Substitution in the GFFKR Sequence of the Cytoplasmic Domain of the Integrin alpha IIb Subunit in a Patient With a Glanzmann's Thrombasthenia-Like Syndrome
Blood,
December 1, 1998;
92(11):
4178 - 4187.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Grimaldi, F. Chen, C. Wu, H. J. Weiss, B. S. Coller, and D. L. French
Glycoprotein IIb Leu214Pro Mutation Produces Glanzmann Thrombasthenia With Both Quantitative and Qualitative Abnormalities in GPIIb/IIIa
Blood,
March 1, 1998;
91(5):
1562 - 1571.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
